Abbott Laboratories (ABT) Acquisitions (2009 - 2019)

Abbott Laboratories (ABT) has 11 years of Acquisitions data on file, last reported at $82.0 million in Q2 2019.

• For the quarter ending Q2 2019, Acquisitions rose 355.56% year-over-year to $82.0 million; the trailing twelve-month figure through Jun 2019 stood at $203.0 million (down 95.17% YoY), and the FY2017 full-year result was $17.2 billion, up 21378.75% from the prior year.
• Acquisitions rose to $82.0 million in Q2 2019, from $78.0 million in the prior quarter.
• In the past five years, Acquisitions ranged from a high of $13.0 billion in Q1 2017 to a low of $7.0 million in Q4 2016.
• A 5-year average of $2.0 billion and a median of $78.0 million in 2019 frame the typical range for Acquisitions.
• Across the five-year window, Acquisitions surged 59271.43% in 2017 and plunged 99.81% in 2018, its largest moves.
• Tracing ABT's Acquisitions over 5 years: stood at $231.0 million in 2015, then slumped by 96.97% to $7.0 million in 2016, then surged by 59271.43% to $4.2 billion in 2017, then slumped by 99.57% to $18.0 million in 2018, then jumped by 355.56% to $82.0 million in 2019.
• Business Quant data shows ABT's Acquisitions at $82.0 million in Q2 2019, $78.0 million in Q1 2019, and $18.0 million in Q2 2018.